TimesSquare Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.7M Buy
456,083
+20,396
+5% +$2.85M 0.91% 36
2025
Q4
$71.4M Buy
435,687
+73,558
+20% +$11.5M 1.08% 31
2025
Q3
$48.4M Buy
362,129
+121,898
+51% +$14.8M 0.69% 57
2025
Q2
$29.9M Buy
240,231
+4,244
+2% +$540K 0.43% 89
2025
Q1
$30M Sell
235,987
-25,005
-10% -$3.85M 0.48% 81
2024
Q4
$37.6M Sell
260,992
-14,635
-5% -$2.1M 0.55% 80
2024
Q3
$41M Buy
275,627
+35,115
+15% +$5.04M 0.61% 65
2024
Q2
$30.3M Buy
240,512
+46,439
+24% +$7.28M 0.48% 84
2024
Q1
$35.7M Sell
194,073
-11,810
-6% -$2.25M 0.52% 78
2023
Q4
$37M Buy
205,883
+78,591
+62% +$12.2M 0.54% 75
2023
Q3
$20.2M Sell
127,292
-102,636
-45% -$16.8M 0.32% 115
2023
Q2
$32.5M Buy
229,928
+57,233
+33% +$9.18M 0.47% 94
2023
Q1
$29.1M Buy
+172,695
New +$30.8M 0.42% 103
2018
Q4
Sell
-803,991
Closed -$44.6M 234
2018
Q3
$44.6M Sell
803,991
-1,272,515
-61% -$65.6M 0.3% 134
2018
Q2
$97.7M Sell
2,076,506
-244,127
-11% -$10M 0.65% 41
2018
Q1
$84M Sell
2,320,633
-190,487
-8% -$6.7M 0.57% 61
2017
Q4
$91.1M Buy
2,511,120
+196,900
+9% +$7.13M 0.6% 55
2017
Q3
$88.7M Sell
2,314,220
-47,050
-2% -$1.97M 0.59% 55
2017
Q2
$97.9M Buy
2,361,270
+390,545
+20% +$14.8M 0.63% 46
2017
Q1
$69.4M Buy
1,970,725
+512,300
+35% +$16.2M 0.45% 88
2016
Q4
$44.9M Buy
1,458,425
+55,600
+4% +$1.72M 0.3% 132
2016
Q3
$42.4M Buy
+1,402,825
New +$42.3M 0.27% 143

Other funds holding RGEN

TimesSquare Capital Management's RGEN Position: Q1 2026 in Review

TimesSquare Capital Management increased its Repligen (RGEN) stake by 4.7% in Q1 2026, buying an estimated $2.85M and bringing the position to 456,083 shares worth $53.7M. The position accounts for 0.91% of the portfolio, ranked #36.

TimesSquare Capital Management first reported a position in RGEN in Q3 2016 and has held it in 22 quarters since. The position peaked at $97.9M in Q2 2017. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • TimesSquare Capital Management held 456,083 shares of Repligen worth $53.7M as of Q1 2026.
  • TimesSquare Capital Management bought 20,396 Repligen shares in Q1 2026, an estimated $2.85M.
  • Repligen made up 0.91% of TimesSquare Capital Management's portfolio in Q1 2026, its #36 holding.
  • TimesSquare Capital Management first reported a position in Repligen in Q3 2016 and has held it in 22 quarters since.
  • TimesSquare Capital Management's Repligen position peaked at $97.9M in Q2 2017.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on TimesSquare Capital Management's 13F filing for Q1 2026, filed 7 May 2026.